Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.

Nawal Al Kaabi,Yunkai Yang,Salah Eldin Hussein,Tian Yang,Jehad Abdalla,Hui Wang,Zhiyong Lou,Chinese Center For Disease Control And Prevention,Agyad Bakkour, Afnan Arafat, China National Biotec Group Company Limited,Zhiwei Jiang,Ye Tian, National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltd, Beijing Institute Of Biological Products Company Limited,Peng Xiao,Walid Zaher,Islam Eltantawy,Chenlong Wang,Guangxue Xu,Yuntao Zhang,Xiaoming Yang

Vaccines(2023)

引用 3|浏览11
暂无评分
摘要
This study is registered on ClinicalTrials.gov (NCT04510207).
更多
查看译文
关键词
COVID-19,SARS-CoV-2,booster dose,inactivated vaccines,phase 3 trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要